Annotations: 2GTJ

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	hSH3	e2gtjA1	A: beta barrels	X: SH3	H: SH3	T: SH3	F: hSH3	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	2.30.30.40	Mainly Beta	Roll	SH3 type barrels.	SH3 Domains	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF07653	Variant SH3 domain (SH3_2)	Variant SH3 domain	SH3 (Src homology 3) domains are often indicative of a protein involved in signal transduction related to cytoskeletal organisation. First described in the Src cytoplasmic tyrosine kinase Swiss:P12931. The structure is a partly opened beta barrel.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	FYN-binding protein	protein binding binding signaling receptor binding lipid binding protein-containing complex binding	cellular response to stimulus immune response-regulating cell surface receptor signaling pathway regulation of cellular process response to stimulus signaling positive regulation of biological process cell communication positive regulation of response to stimulus immune response-activating signaling pathway immune response-regulating signaling pathway positive regulation of immune response regulation of immune system process signal transduction positive regulation of immune system process cellular response to stimulus immune response-regulating cell surface receptor signaling pathway regulation of cellular process response to stimulus signaling positive regulation of biological process cell communication positive regulation of response to stimulus immune response-activating signaling pathway immune response-regulating signaling pathway positive regulation of immune response regulation of immune system process signal transduction positive regulation of immune system process regulation of biological process cell surface receptor signaling pathway immune response-activating cell surface receptor signaling pathway immune response biological regulation T cell receptor signaling pathway regulation of response to stimulus immune system process regulation of immune response cellular process antigen receptor-mediated signaling pathway activation of immune response integrin-mediated signaling pathway protein localization localization protein localization to cell periphery cellular localization protein localization to plasma membrane cellular macromolecule localization macromolecule localization localization within membrane protein localization to membrane	intracellular organelle intracellular anatomical structure cytoskeleton organelle intracellular non-membrane-bounded organelle cellular anatomical entity actin cytoskeleton non-membrane-bounded organelle cytoplasm cytosol anchoring junction cell junction cell periphery plasma membrane intracellular organelle intracellular anatomical structure cytoskeleton organelle intracellular non-membrane-bounded organelle cellular anatomical entity actin cytoskeleton non-membrane-bounded organelle cytoplasm cytosol anchoring junction cell junction cell periphery plasma membrane membrane protein-containing complex membrane-bounded organelle nucleus intracellular membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR043443	FYN-binding protein 1/2-like	Family
A	IPR035540	FYB, helically extended SH3 domain	Domain
A	IPR029294	Helically-extended SH3 domain	Domain
A	IPR001452	SH3 domain	Domain
A	IPR036028	SH3-like domain superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: O15117	thrombocytopenia 3 allergic contact dermatitis osteosarcoma psoriasis Sjogren syndrome tuberculosis acute myeloid leukemia B-cell chronic lymphocytic leukemia chronic obstructive pulmonary disease glioblastoma invasive ductal breast carcinoma lung carcinoma MALT lymphoma ovarian cancer rheumatoid arthritis thrombocytopenia 3 allergic contact dermatitis osteosarcoma psoriasis Sjogren syndrome tuberculosis acute myeloid leukemia B-cell chronic lymphocytic leukemia chronic obstructive pulmonary disease glioblastoma invasive ductal breast carcinoma lung carcinoma MALT lymphoma ovarian cancer rheumatoid arthritis subependymal giant cell astrocytoma ulcerative colitis age-related macular degeneration breast cancer cutaneous lupus erythematosus head and neck cancer large cell medulloblastoma malignant colon neoplasm medulloblastoma pilocytic astrocytoma sarcoidosis wet macular degeneration breast carcinoma diabetes mellitus interstitial cystitis lung cancer malignant glioma

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.